BYETTA Side Effects

7023530-5 | Blood Triglycerides Decreased, Pancreatitis
on Sep 30, 2010 Male patient from UNITED STATES , weighting 290.6 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: blood triglycerides decreased, pancreatitis. Byetta dosage: 10 Mcg Bid Sub Q. Patient was hospitalized.

7023502-0 | Abdominal Pain Upper, Adenocarcinoma Pancreas, Weight Decreased
Patient was taking Byetta (View Usage). Patient had the following side effects: abdominal pain upper, adenocarcinoma pancreas, weight decreased on Sep 29, 2010 from UNITED STATES Additional patient health information: Male patient , 69 years of age, weighting 254.0 lb, was diagnosed with diabetes mellitus, obesity (What is obesity?) and. Byetta dosage: 10 Mcg Twice A Day Sq.

7022505-X | Asthenia, Blood Glucose Decreased, Coronary Artery Occlusion, Off Label Use, Sleep Disorder, Tremor, Weight Decreased
Adverse event was reported on Sep 20, 2010 by a Female patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus, hypertension and. Location: UNITED STATES , weighting 160.0 lb, After Byetta was administered, patient had the following side effects: asthenia, blood glucose decreased, coronary artery occlusion, off label use, sleep disorder (What is sleep disorder?), tremor, weight decreased. During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), DIGOXIN (Unk, Daily (1/d)) (View Digoxin Review and Digoxin Label ), IMDUR (View Imdur Review and Imdur Label ), PLAVIX (75 Mg, Daily (1/d)) (View Plavix Review and Plavix Label ), BUPROPION HCL (150 Mg, 2/d) (View Bupropion Hcl Review and Bupropion Hcl Label ), LIPITOR (10 Mg, Unk) (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

7021469-2 | Cholelithiasis, Hepatic Cirrhosis, Hepatocellular Injury, Hepatomegaly, Off Label Use, Pancreatitis Acute, Pancreatitis Chronic, Pyelonephritis, Splenomegaly
on Sep 27, 2010 Female patient from UNITED STATES , weighting 195.0 lb, was diagnosed with diabetes mellitus, lipids and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: cholelithiasis, hepatic cirrhosis, hepatocellular injury, hepatomegaly, off label use, pancreatitis acute, pancreatitis chronic, pyelonephritis, splenomegaly. Byetta dosage: 10 Ug, 2/d. During the same period patient was treated with METFORMIN (500 Mg, Each Morning) (View Metformin Review and Metformin Label ), GLYBURIDE (5 Mg, Each Morning) (View Glyburide Review and Glyburide Label ), ACTOS (View Actos Review and Actos Label ), NOVOLOG (5 U, 3/d) (View Novolog Review and Novolog Label ), SIMVASTATIN (40 Mg, Daily (1/d)) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.


7021468-0 | Abdominal Pain, Nausea, Renal Failure, Weight Decreased
on Sep 24, 2010 Female patient from FRANCE , 50 years of age, was treated with Byetta (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), nausea (What is nausea?), renal failure, weight decreased. Byetta dosage: 10 Ug, Unk. During the same period patient was treated with BIGUANIDES (View Biguanides Review and Biguanides Label ), ENZYME INHIBITORS (View Enzyme Inhibitors Review and Enzyme Inhibitors Label ). Patient was hospitalized.

7021465-5 | Chest Pain, Incorrect Dose Administered, Pancreatitis Acute, Renal Injury
Patient was taking Byetta (View Usage). After Byetta was administered, patient had the following side effects: chest pain (What is chest pain?), incorrect dose administered, pancreatitis acute, renal injury on Sep 27, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 203.0 lb, was diagnosed with blood pressure (What is blood pressure?), diabetes mellitus and. Byetta dosage: 5 Mg, Daily (1/d). During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LEVOTHYROXINE /00068001/ (112 Mg, Daily (1/d)) (View Levothyroxine /00068001/ Review and Levothyroxine /00068001/ Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), GLIMEPIRIDE (8 Mg, Daily (1/d)) (View Glimepiride Review and Glimepiride Label ), ACTOS (45 Mg, Daily (1/d)) (View Actos Review and Actos Label ), METFORMIN (1000 Mg, Unk) (View Metformin Review and Metformin Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ).

7021462-X | Dehydration, Off Label Use, Pancreatitis Acute, Renal Failure Acute
Adverse event was reported on Sep 27, 2010 by a Female patient taking Byetta (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hypertension, cardiomyopathy (What is cardiomyopathy?), hypertriglyceridaemia, hypercholesterolaemia and. Location: UNITED STATES , weighting 127.0 lb, Patient experienced the following unwanted or unexpected effects: dehydration, off label use, pancreatitis acute, renal failure acute. During the same period patient was treated with LANTUS (55 U, Each Evening) (View Lantus Review and Lantus Label ), COREG (25 Mg, 2/d) (View Coreg Review and Coreg Label ), DIGOXIN (0.25 Mg, Daily (1/d)) (View Digoxin Review and Digoxin Label ), ENALAPRIL MALEATE (10 Mg, 2/d) (View Enalapril Maleate Review and Enalapril Maleate Label ), TRICOR (145 Mg, Daily (1/d)) (View Tricor Review and Tricor Label ), CRESTOR (10 Mg, Daily (1/d)) (View Crestor Review and Crestor Label ). Patient was hospitalized.

7021461-8 | Blood Glucose Increased, Dyspnoea Exertional, Hypoxia, Pancreatitis Acute, Renal Disorder
on Sep 27, 2010 Male patient from UNITED STATES , weighting 220.0 lb, was diagnosed with type 2 diabetes mellitus, blood cholesterol increased and was treated with Byetta (View Usage). Patient had the following side effects: blood glucose increased, dyspnoea exertional, hypoxia, pancreatitis acute, renal disorder. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), LIPITOR (40 Mg, Daily (1/d)) (View Lipitor Review and Lipitor Label ), GLIPIZIDE (10 Mg, 2/d) (View Glipizide Review and Glipizide Label ), LISINOPRIL (20 Mg, 2/d) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

7021450-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bilirubin Conjugated Increased, Blood Calcium Increased, Blood Sodium Decreased, Gamma-glutamyltransferase Increased, Nausea
on Sep 21, 2010 Female patient from GERMANY , weighting 141.1 lb, was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia, hypertension and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood calcium increased, blood sodium decreased, gamma-glutamyltransferase increased, nausea (What is nausea?). Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with METFORMIN (1 G, 2/d) (View Metformin Review and Metformin Label ), FLUVASTATIN (80 Mg, Daily (1/d)) (View Fluvastatin Review and Fluvastatin Label ), CARMEN (10 Mg, 2/d) (View Carmen Review and Carmen Label ), BISOPROLOL (2.5 Mg, Daily (1/d)) (View Bisoprolol Review and Bisoprolol Label ), HCT (25 Mg, Daily (1/d)) (View Hct Review and Hct Label ). Patient was hospitalized.

7021448-5 | Fatigue, Feeling Abnormal, Off Label Use, Treatment Noncompliance, Urinary Tract Infection
Patient was taking Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, feeling abnormal, off label use, treatment noncompliance, urinary tract infection (What is urinary tract infection?) on Sep 20, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 210.0 lb, was diagnosed with type 2 diabetes mellitus and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with LANTUS (30 D/f, Each Evening) (View Lantus Review and Lantus Label ). Patient was hospitalized.

7021447-3 | Blood Creatinine Increased, Incorrect Dose Administered
Adverse event was reported on Sep 21, 2010 by a Male patient taking Byetta (View Usage) (Dosage: 1.2 Mg, Unk) was diagnosed with diabetes mellitus and. Location: UNITED KINGDOM , 63 years of age, weighting 280.0 lb, Patient had the following side effects: blood creatinine increased, incorrect dose administered. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), METFORMIN (View Metformin Review and Metformin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

7017784-9 | Blood Glucose Increased, Dizziness, Glycosylated Haemoglobin Increased, Nausea, Syncope
on Sep 17, 2010 Female patient from UNITED STATES , weighting 197.0 lb, was diagnosed with type 2 diabetes mellitus, thyroid disorder, fibromyalgia and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: blood glucose increased, dizziness (What is dizziness?), glycosylated haemoglobin increased, nausea (What is nausea?), syncope. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with SYNTHROID (1.25 Mg, Each Morning) (View Synthroid Review and Synthroid Label ), CENESTIN (0.9 Mg, Daily (1/d)) (View Cenestin Review and Cenestin Label ), CYMBALTA (60 Mg, Daily (1/d)) (View Cymbalta Review and Cymbalta Label ), RITALIN (10 Mg, As Needed) (View Ritalin Review and Ritalin Label ).

7017780-1 | Blood Glucose Decreased, Blood Glucose Increased, Decreased Appetite, Hypertension, Loss Of Consciousness, Mental Status Changes, Tremor, Weight Increased
on Sep 17, 2010 Female patient from UNITED STATES , weighting 194.0 lb, was diagnosed with gestational diabetes and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, blood glucose increased, decreased appetite, hypertension, loss of consciousness, mental status changes, tremor, weight increased. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with METFORMIN (500 Mg, 3/d) (View Metformin Review and Metformin Label ), IBUPROFEN (800 Mg, 3/d) (View Ibuprofen Review and Ibuprofen Label ), METOPROLOL TARTRATE (100 Mg, 2/d) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), NIFEDIPINE (60 Mg, Daily (1/d)) (View Nifedipine Review and Nifedipine Label ), CLONIDINE (0.2 Mg, 3/d) (View Clonidine Review and Clonidine Label ), OMEPRAZOLE (Unk, Daily (1/d)) (View Omeprazole Review and Omeprazole Label ), HYDROCODONE BITARTRATE AND ACETAMINOPHEN (Unk, 3/d) (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ).

7014412-3 | Back Pain, Pancreatitis, Rash Papular
Patient was taking Byetta (View Usage). Patient had the following side effects: back pain (What is back pain?), pancreatitis, rash papular on Sep 15, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 221.0 lb, was diagnosed with type 2 diabetes mellitus and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with DIOVAN (160 Mg, Daily (1/d)) (View Diovan Review and Diovan Label ).

7014398-1 | Cholelithiasis, Dizziness, Nausea, Non-cardiac Chest Pain
Adverse event was reported on Sep 15, 2010 by a Female patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus, asthma (What is asthma?), thyroid disorder and. Location: UNITED STATES , weighting 168.0 lb, After Byetta was administered, patient had the following side effects: cholelithiasis, dizziness (What is dizziness?), nausea (What is nausea?), non-cardiac chest pain. During the same period patient was treated with JANUVIA (100 Mg, Daily (1/d)) (View Januvia Review and Januvia Label ), SINGULAIR (10 Mg, Daily (1/d)) (View Singulair Review and Singulair Label ), SYNTHROID (250 Mg, Daily (1/d)) (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

7014396-8 | Arthritis, Asthenia, Blood Glucose Increased, Blood Pressure Abnormal, Bone Disorder, Diarrhoea, Heart Rate Decreased, Mobility Decreased
on Sep 16, 2010 Female patient from UNITED STATES , weighting 275.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), asthenia, blood glucose increased, blood pressure abnormal, bone disorder, diarrhoea, heart rate decreased, mobility decreased. Byetta dosage: 5 Ug, 2/d. Patient was hospitalized and became disabled.

7009380-4 | Blood Glucose Increased, Cardiac Disorder, Depression, Mood Altered, Nasal Polyps, Post-traumatic Stress Disorder
on Sep 15, 2010 Male patient from UNITED STATES , weighting 190.0 lb, was diagnosed with type 2 diabetes mellitus, nightmare, depression (What is depression?), blood cholesterol increased and was treated with Byetta (View Usage). Patient had the following side effects: blood glucose increased, cardiac disorder, depression (What is depression?), mood altered, nasal polyps, post-traumatic stress disorder (What is post-traumatic stress disorder?). Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with PRAZOSIN HCL (Unk, Each Evening) (View Prazosin Hcl Review and Prazosin Hcl Label ), ARIPIPRAZOLE (Unk, Each Evening) (View Aripiprazole Review and Aripiprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LEVOTHYROXINE SODIUM (0.125 Ug, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), VENLAFAXINE HCL (Unk, Daily (1/d)) (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), PLAVIX (75 Mg, Unk) (View Plavix Review and Plavix Label ).

7006896-1 | Amnesia, Arrhythmia, Arthralgia, Atrial Fibrillation, Blood Cholesterol Increased, Blood Glucose Decreased, Blood Glucose Increased, Bradycardia, Cardiac Disorder
Patient was taking Byetta (View Usage). After Byetta was administered, patient had the following side effects: amnesia, arrhythmia (What is arrhythmia?), arthralgia, atrial fibrillation (What is atrial fibrillation?), blood cholesterol increased, blood glucose decreased, blood glucose increased, bradycardia, cardiac disorder on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 183.0 lb, was diagnosed with type 2 diabetes mellitus, depression (What is depression?), muscle spasms and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with HUMALOG (Unk, As Needed) (View Humalog Review and Humalog Label ), PRANDIN (1 Mg, Each Morning) (View Prandin Review and Prandin Label ), COREG CR (20 Mg, Daily (1/d)) (View Coreg Cr Review and Coreg Cr Label ), COZAAR (100 Mg, Daily (1/d)) (View Cozaar Review and Cozaar Label ), COUMADIN (7.5 Mg, 4/w) (View Coumadin Review and Coumadin Label ), ZOLOFT (50 Mg, Daily (1/d)) (View Zoloft Review and Zoloft Label ), VALIUM (5 Mg, As Needed) (View Valium Review and Valium Label ). Patient was hospitalized.

7006895-X | Blood Glucose Decreased, Blood Glucose Increased, Hypoaesthesia, Myocardial Infarction, Oedema Peripheral, Off Label Use, Staphylococcal Infection, Tremor
Adverse event was reported on Sep 14, 2010 by a Female patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus, thyroid disorder, hormone level abnormal, nervousness and. Location: UNITED STATES , weighting 185.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose decreased, blood glucose increased, hypoaesthesia, myocardial infarction, oedema peripheral, off label use, staphylococcal infection (What is staphylococcal infection?), tremor. During the same period patient was treated with LANTUS (80 U, As Needed) (View Lantus Review and Lantus Label ), NOVOLOG MIX 70/30 (Unk, As Needed) (View Novolog Mix 70/30 Review and Novolog Mix 70/30 Label ), SYNTHROID (75 Mg, Daily (1/d)) (View Synthroid Review and Synthroid Label ), ESTRATEST (Unk, Daily (1/d)) (View Estratest Review and Estratest Label ), PLAVIX (View Plavix Review and Plavix Label ), XANAX (1 Mg, 3/d) (View Xanax Review and Xanax Label ). Patient was hospitalized.

7006888-2 | Epistaxis, International Normalised Ratio Increased
on Sep 14, 2010 Male patient from UNITED STATES , weighting 184.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). Patient had the following side effects: epistaxis, international normalised ratio increased. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with WARFARIN SODIUM (Unk, Daily (1/d)) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

7006885-7 | Blood Glucose Increased, Breast Cancer, Breast Mass, Infection, Tympanic Membrane Perforation
on Sep 13, 2010 Female patient from UNITED STATES , weighting 168.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: blood glucose increased, breast cancer (What is breast cancer?), breast mass, infection (What is infection?), tympanic membrane perforation. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with ACTOS (15 Mg, Daily (1/d)) (View Actos Review and Actos Label ). Patient was hospitalized.

7005826-6 | Gastric Ulcer, Gastric Varices, Pancreatic Carcinoma
Patient was taking Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: gastric ulcer, gastric varices, pancreatic carcinoma on Sep 15, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 43 years of age, weighting 185.2 lb, was diagnosed with type 2 diabetes mellitus and. Byetta dosage: . During the same period patient was treated with ASPIRIN (75 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), CITALOPRAM HYDROBROMIDE (40 Mg, Daily (1/d)) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), METFORMIN (1 G, 2/d) (View Metformin Review and Metformin Label ), PIOGLITAZONE (30 Mg, Daily (1/d)) (View Pioglitazone Review and Pioglitazone Label ), SIMVASTATIN (40 Mg, Daily (1/d)) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

7005820-5 | Chest Discomfort, Coronary Artery Disease
Adverse event was reported on Sep 15, 2010 by a Male patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus, prophylaxis and. Location: UNITED STATES , weighting 304.9 lb, Patient had the following side effects: chest discomfort, coronary artery disease (What is coronary artery disease?). During the same period patient was treated with ASPIRIN (81 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

7005765-0 | Pancreatitis, Renal Failure Acute, Weight Decreased
on Sep 10, 2010 Female patient from UNITED STATES , 67 years of age, weighting 206.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: pancreatitis, renal failure acute, weight decreased. Byetta dosage: 10 Ug, 2/d. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), COREG (View Coreg Review and Coreg Label ), PROTONIX (View Protonix Review and Protonix Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ACTOS (View Actos Review and Actos Label ), LIPITOR (View Lipitor Review and Lipitor Label ), TRICOR (View Tricor Review and Tricor Label ). Patient was hospitalized.

6997957-1 | Pancreatitis
on Sep 13, 2010 Male patient from UNITED STATES , 65 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ).

6997954-6 | Off Label Use, Pancreatic Neoplasm
Patient was taking Byetta (View Usage). Patient had the following side effects: off label use, pancreatic neoplasm on Sep 14, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 66 years of age, was diagnosed with diabetes mellitus and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with GLICLAZIDE (160 Mg, 2/d) (View Gliclazide Review and Gliclazide Label ), LANTUS (View Lantus Review and Lantus Label ), METFORMIN (1 G, 2/d) (View Metformin Review and Metformin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ).

6997953-4 | Abdominal Pain, Anaemia, Coma, Dehydration, Diarrhoea, Glycosylated Haemoglobin Increased, Lactic Acidosis, Nausea, Renal Failure Acute
Adverse event was reported on Sep 13, 2010 by a Female patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus, hypertension and. Location: FRANCE , weighting 176.4 lb, After Byetta was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, coma, dehydration, diarrhoea, glycosylated haemoglobin increased, lactic acidosis, nausea (What is nausea?), renal failure acute. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), BISOPROLOL FUMARATE (5 Mg, Daily (1/d)) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

6997951-0 | Blood Cholesterol Increased, Pancreatitis
on Sep 14, 2010 Female patient from UNITED STATES , weighting 255.0 lb, was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol increased, pancreatitis. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with SULINDAC (View Sulindac Review and Sulindac Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ACTOS (View Actos Review and Actos Label ), METFORMIN (View Metformin Review and Metformin Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6997949-2 | Blood Glucose Decreased, Blood Glucose Increased, Device Occlusion, Myocardial Infarction, Stent Placement
on Sep 14, 2010 Male patient from UNITED STATES , weighting 187.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). Patient had the following side effects: blood glucose decreased, blood glucose increased, device occlusion, myocardial infarction, stent placement. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with METFORMIN (850 Mg, 2/d) (View Metformin Review and Metformin Label ), GLYBURIDE (10 Mg, 2/d) (View Glyburide Review and Glyburide Label ), ZOCOR (40 Mg, Unk) (View Zocor Review and Zocor Label ), KLOR CON (20 Meq, Unk) (View Klor-con Review and Klor-con Label ), BUMEX (2 Mg, 2/d) (View Bumex Review and Bumex Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.

6997948-0 | Cholelithiasis, Weight Decreased
Patient was taking Byetta (View Usage). After Byetta was administered, patient had the following side effects: cholelithiasis, weight decreased on Sep 08, 2010 from ARGENTINA Additional patient health information: Female patient , 45 years of age, was diagnosed with type 2 diabetes mellitus and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ). Patient was hospitalized.

6994289-2 | Off Label Use, Thyroid Neoplasm
Adverse event was reported on Sep 10, 2010 by a Female patient taking Byetta (View Usage) (Dosage: ) . Location: UNITED STATES , 76 years of age, Patient experienced the following unwanted or unexpected effects: off label use, thyroid neoplasm. During the same period patient was treated with HUMALOG (Unk, Unk) (View Humalog Review and Humalog Label ), EVISTA (View Evista Review and Evista Label ), ZOCOR (View Zocor Review and Zocor Label ), COZAAR (Unk, Unk) (View Cozaar Review and Cozaar Label ), LASIX (View Lasix Review and Lasix Label ), LOVAZA (View Lovaza Review and Lovaza Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AMBIEN (View Ambien Review and Ambien Label ).

6988748-6 | Glycosylated Haemoglobin Increased, Oesophagitis, Off Label Use, Weight Increased
on Sep 09, 2010 Male patient from UNITED STATES , 68 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). Patient had the following side effects: glycosylated haemoglobin increased, oesophagitis, off label use, weight increased. Byetta dosage: 10 Ug, Unk. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), ACTOS (View Actos Review and Actos Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6988747-4 | Back Pain, Pancreatitis, Rash Papular, Sjogren's Syndrome
on Sep 09, 2010 Female patient from UNITED STATES , weighting 221.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: back pain (What is back pain?), pancreatitis, rash papular, sjogren's syndrome (What is sjogren's syndrome?). Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with DIOVAN (160 Mg, Daily (1/d)) (View Diovan Review and Diovan Label ).

6988746-2 | Diarrhoea, Gastrointestinal Inflammation, Glycosylated Haemoglobin Increased, Haematochezia
Patient was taking Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, gastrointestinal inflammation, glycosylated haemoglobin increased, haematochezia on Sep 10, 2010 from DENMARK Additional patient health information: Female patient , 47 years of age, was diagnosed with type 2 diabetes mellitus and. Byetta dosage: 10 Ug, 2/d. During the same period patient was treated with PREDNISOLON (View Prednisolon Review and Prednisolon Label ). Patient was hospitalized.

6988743-7 | Pain In Extremity
Adverse event was reported on Sep 09, 2010 by a Male patient taking Byetta (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED KINGDOM , 72 years of age, weighting 216.1 lb, Patient had the following side effects: pain in extremity.

6988742-5 | Chest Pain, Oesophagitis, Off Label Use
on Sep 09, 2010 Male patient from UNITED STATES , 61 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: chest pain (What is chest pain?), oesophagitis, off label use. Byetta dosage: 10 Ug, 2/d. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), ACTOS (View Actos Review and Actos Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6988697-3 | Glycosylated Haemoglobin Increased
on Sep 08, 2010 Male patient from UNITED KINGDOM , weighting 246.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: glycosylated haemoglobin increased. Byetta dosage: 5 Ug, Daily (1/d). During the same period patient was treated with METFORMIN (1350 Mg, Daily (1/d)) (View Metformin Review and Metformin Label ), GLICLAZIDE (80 Mg, 2/d) (View Gliclazide Review and Gliclazide Label ).

6988695-X | Abdominal Distension, Abdominal Rigidity, Blood Glucose Fluctuation, Blood Glucose Increased, Cold Sweat, Crying, Decreased Appetite, Dizziness
Patient was taking Byetta (View Usage). Patient had the following side effects: abdominal distension, abdominal rigidity, blood glucose fluctuation, blood glucose increased, cold sweat, crying, decreased appetite, dizziness (What is dizziness?) on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 233.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with SYNTHROID (0.75 Ug, Daily (1/d)) (View Synthroid Review and Synthroid Label ), ESTRACE (View Estrace Review and Estrace Label ), PROVERA (View Provera Review and Provera Label ), DIOVAN /SCH/ (View Diovan /sch/ Review and Diovan /sch/ Label ). Patient was hospitalized.

6988694-8 | Blood Glucose Increased, Glycosylated Haemoglobin Increased
Adverse event was reported on Sep 08, 2010 by a Male patient taking Byetta (View Usage) (Dosage: 5 Ug, Daily (1/d)) was diagnosed with type 2 diabetes mellitus and. Location: UNITED KINGDOM , weighting 310.9 lb, After Byetta was administered, patient had the following side effects: blood glucose increased, glycosylated haemoglobin increased. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ).

6988689-4 | Cholelithiasis
on Sep 08, 2010 Female patient from UNITED KINGDOM , 68 years of age, was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: cholelithiasis. Byetta dosage: . Patient was hospitalized.

6985977-2 | Bleeding Time Prolonged, Dehydration, Nausea, Renal Failure Acute, Tubulointerstitial Nephritis, Weight Decreased
on Sep 07, 2010 Female patient from UNITED STATES , weighting 144.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). Patient had the following side effects: bleeding time prolonged, dehydration, nausea (What is nausea?), renal failure acute, tubulointerstitial nephritis, weight decreased. Byetta dosage: 5 U, 2/d. During the same period patient was treated with LEXAPRO (20 Mg, Daily (1/d)) (View Lexapro Review and Lexapro Label ), BUSPIRONE HCL (30 Mg, Each Evening) (View Buspirone Hcl Review and Buspirone Hcl Label ), LORAZEPAM (0.5 Mg, 4/d) (View Lorazepam Review and Lorazepam Label ), DIOVAN HCT (320 Mg, Daily (1/d)) (View Diovan Hct Review and Diovan Hct Label ), LIPITOR (20 Mg, Daily (1/d)) (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6985970-X | Pancreatitis Acute
Patient was taking Byetta (View Usage). After Byetta was administered, patient had the following side effects: pancreatitis acute on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 213.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, coronary artery disease (What is coronary artery disease?), dyslipidaemia, multiple allergies, prophylaxis and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with PRINIVIL (Unk, Unk) (View Prinivil Review and Prinivil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOCOR (Unk, Unk) (View Zocor Review and Zocor Label ), IMDUR (Unk, Unk) (View Imdur Review and Imdur Label ), ZYRTEC (Unk, Unk) (View Zyrtec Review and Zyrtec Label ), MULTI VITAMIN (Unk, Unk) (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6985939-5 | Cholelithiasis, Hepatic Cirrhosis, Hospitalisation, Nasopharyngitis, Pollakiuria
Adverse event was reported on Sep 07, 2010 by a Female patient taking Byetta (View Usage) (Dosage: 10 Ug, 2/d) was diagnosed with type 2 diabetes mellitus and. Location: GERMANY , weighting 216.1 lb, Patient experienced the following unwanted or unexpected effects: cholelithiasis, hepatic cirrhosis, hospitalisation, nasopharyngitis, pollakiuria. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), IBUPROFEN (Unk, As Needed) (View Ibuprofen Review and Ibuprofen Label ), NOVALGIN (Unk, As Needed) (View Novalgin Review and Novalgin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6985936-X | Pancreatitis
on Sep 02, 2010 Female patient from UNITED STATES , 50 years of age, was diagnosed with blood pressure (What is blood pressure?) and was treated with Byetta (View Usage). Patient had the following side effects: pancreatitis. Byetta dosage: 5 Ug, Unk. During the same period patient was treated with DIOVAN (1 D/f, Unk) (View Diovan Review and Diovan Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASPIRIN (88 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6985934-6 | Renal Failure
on Sep 03, 2010 Female patient from BRAZIL , 64 years of age, was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: renal failure. Byetta dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), ACTOS /BRA/ (View Actos /bra/ Review and Actos /bra/ Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), XENICAL (View Xenical Review and Xenical Label ), ZOLOFT (View Zoloft Review and Zoloft Label ).

6985933-4 | Asthenia, Nausea, Renal Failure, Weight Decreased
Patient was taking Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, nausea (What is nausea?), renal failure, weight decreased on Sep 07, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 60 years of age, . Byetta dosage: . Patient was hospitalized.

6977249-7 | Off Label Use, Pancreatic Carcinoma Metastatic, Weight Decreased
Adverse event was reported on Sep 01, 2010 by a Male patient taking Byetta (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hyperlipidaemia, hypertension and. Location: UNITED STATES , weighting 250.0 lb, Patient had the following side effects: off label use, pancreatic carcinoma metastatic, weight decreased. During the same period patient was treated with ACTOS /SCH/ (15 Mg, Unk) (View Actos /sch/ Review and Actos /sch/ Label ), GLIMEPIRIDE (4 Mg, 2/d) (View Glimepiride Review and Glimepiride Label ), METFORMIN HYDROCHLORIDE (1 D/f, 2/d) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), LANTUS (View Lantus Review and Lantus Label ), CRESTOR (5 Mg, Unk) (View Crestor Review and Crestor Label ), DIOVAN (160 Mg, Unk) (View Diovan Review and Diovan Label ), JANUVIA (100 Mg, Unk) (View Januvia Review and Januvia Label ). Patient was hospitalized.

6977246-1 | Cerebrovascular Accident, Encephalopathy, Renal Failure Chronic
on Aug 31, 2010 Male patient from UNITED STATES , 63 years of age, was diagnosed with diabetes mellitus and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: cerebrovascular accident, encephalopathy, renal failure chronic. Byetta dosage: . Patient was hospitalized.

6977244-8 | Blood Cholesterol Increased, Decreased Appetite, Mitral Valve Disease, Mitral Valve Incompetence, Off Label Use, Pancreatitis, Renal Failure, Thyroid Cancer, Weight Decreased
on Sep 03, 2010 Female patient from UNITED STATES , weighting 219.0 lb, was diagnosed with type 2 diabetes mellitus, dyslipidaemia, hypothyroidism and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol increased, decreased appetite, mitral valve disease, mitral valve incompetence, off label use, pancreatitis, renal failure, thyroid cancer (What is thyroid cancer?), weight decreased. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with ACCUPRIL (40 Mg, 2/d) (View Accupril Review and Accupril Label ), METFORMIN HYDROCHLORIDE (850 Mg, 3/d) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), LEVEMIR (20 D/f, Each Morning) (View Levemir Review and Levemir Label ), ZETIA (10 Mg, Unk) (View Zetia Review and Zetia Label ), LIPITOR (40 Mg, Unk) (View Lipitor Review and Lipitor Label ), LEVOTHYROXINE SODIUM (0.137 Ug, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ATENOLOL (50 Mg, 2/d) (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6975823-5 | Abdominal Distension, Blood Cholesterol Increased, Blood Glucose Increased, Decreased Appetite, Dehydration, Dyspepsia, Eructation, Flatulence
Patient was taking Byetta (View Usage). Patient had the following side effects: abdominal distension, blood cholesterol increased, blood glucose increased, decreased appetite, dehydration, dyspepsia, eructation, flatulence on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 175.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, gastrooesophageal reflux disease, hypertonic bladder, sleep disorder (What is sleep disorder?) and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with TRANDOLAPRIL (Unk, Unk) (View Trandolapril Review and Trandolapril Label ), HYDROCHLOROTHIAZIDE (25 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PROTONIX (View Protonix Review and Protonix Label ), ENABLEX /01760401/ (15 Mg, Unk) (View Enablex /01760401/ Review and Enablex /01760401/ Label ), AMBIEN CR (View Ambien Cr Review and Ambien Cr Label ). Patient was hospitalized.